| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 122.163 | 62.023 | 165.570 | 125.866 | 154.862 | 261.707 | 309.947 | 334.007 |
| Total Income - EUR | - | 4 | 123.369 | 62.474 | 166.175 | 126.114 | 154.986 | 262.621 | 310.885 | 334.177 |
| Total Expenses - EUR | - | 16.926 | 105.016 | 97.290 | 152.832 | 132.640 | 156.528 | 263.061 | 278.887 | 246.744 |
| Gross Profit/Loss - EUR | - | -16.922 | 18.352 | -34.817 | 13.343 | -6.527 | -1.542 | -440 | 31.999 | 87.433 |
| Net Profit/Loss - EUR | - | -16.922 | 16.842 | -35.437 | 11.686 | -7.753 | -3.091 | -3.057 | 28.899 | 77.413 |
| Employees | - | 1 | 1 | 1 | 3 | 3 | 3 | 6 | 5 | 4 |
Check the financial reports for the company - Sanacro Clinical Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 281 | 1.568 | 916 | 3.885 | 2.163 | 779 | 0 | 1.664 | 2.189 |
| Current Assets | - | 169 | 35.189 | 4.580 | 15.728 | 11.067 | 16.433 | 23.053 | 65.485 | 85.301 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 9.165 | 2.407 | 5.243 | 3.954 | 5.269 | 4.670 | 38.426 | 21.058 |
| Cash | - | 169 | 26.023 | 2.173 | 10.485 | 7.113 | 11.164 | 18.383 | 27.059 | 64.243 |
| Shareholders Funds | - | -16.878 | 250 | -35.583 | -23.208 | -31.853 | -34.237 | -37.401 | -8.388 | 69.071 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 17.328 | 36.506 | 41.079 | 42.820 | 45.083 | 51.450 | 60.453 | 75.538 | 18.418 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Sanacro Clinical Research Srl